Published in Heart Fail Rev on September 01, 2001
Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant (2008) 1.08
Nitric oxide synthases in heart failure. Antioxid Redox Signal (2012) 1.07
The complex role of iNOS in acutely rejecting cardiac transplants. Free Radic Biol Med (2008) 0.80
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant (1991) 5.06
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med (1990) 3.88
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med (1998) 3.76
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell (1995) 3.68
Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature (1995) 3.36
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation (1998) 1.97
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant (1990) 1.91
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol (1991) 1.82
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation (1987) 1.71
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation (1991) 1.62
A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med (1993) 1.54
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46
The complement system in xenotransplantation. Immunopharmacology (1993) 1.44
Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant (1992) 1.40
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation (1984) 1.32
Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol (1990) 1.28
A system for grading cardiac allograft rejection. Tex Heart Inst J (1986) 1.25
The Registry of the International Society for Heart Transplantation: seventh official report--1990. J Heart Transplant (1990) 1.23
CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation (1986) 1.22
Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med (1998) 1.14
The Registry of the International Society for Heart and Lung Transplantation: tenth official report--1993. J Heart Lung Transplant (1993) 1.08
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol (1995) 1.06
Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant (1996) 1.06
Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group. J Heart Lung Transplant (1995) 1.06
Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant (1992) 1.02
Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol (1988) 0.99
Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant (1999) 0.96
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol (1994) 0.96
Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Transplant (1997) 0.94
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant (1999) 0.94
Immunosuppressive agents in clinical trials in transplantation. Am J Med Sci (1997) 0.90
Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant (1990) 0.90
Pathologic features in long-term cardiac allografts. J Heart Transplant (1990) 0.89
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity. J Cell Physiol (1989) 0.89
Immunopathology of cardiac transplant rejection. Curr Opin Cardiol (1995) 0.86
Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J Cell Physiol (1988) 0.86
Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant (1992) 0.85
Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant (1994) 0.85
Laboratory and clinical management of the highly sensitized organ transplant recipient. Hum Immunol (1989) 0.84
Noninvasive methods of rejection diagnosis after heart transplantation. J Heart Lung Transplant (1992) 0.83
Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant (1993) 0.83
Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2. J Cell Physiol (1990) 0.83
Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation (1993) 0.82
Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant (1992) 0.82
Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant (1992) 0.81
Successful coronary artery bypass grafting for high-risk left main coronary artery atherosclerosis after cardiac transplantation. Ann Thorac Surg (1990) 0.81
Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant (1995) 0.80
The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group. J Heart Lung Transplant (1997) 0.80
Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients. J Heart Transplant (1987) 0.80
Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation (1989) 0.80
Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg (1990) 0.80
Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J (1994) 0.80
Transplantation immunology. JAMA (1997) 0.80
Left ventricular function of heart allografts during acute rejection: an echocardiographic assessment. J Heart Transplant (1987) 0.80
Chemotaxis of the monocyte cell line U937: dependence on cholesterol and early mevalonate pathway products. Atherosclerosis (1991) 0.79
Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant (1988) 0.79
Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant (1998) 0.78
Xenotransplantation. FASEB J (1994) 0.78
Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs (1994) 0.78
Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. Am J Cardiol (1994) 0.78
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. Transplantation (1999) 0.78
The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes. Transpl Immunol (1996) 0.78
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. J Heart Lung Transplant (1997) 0.78
Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound. J Heart Lung Transplant (1996) 0.78
Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? J Heart Lung Transplant (1996) 0.78
Directional coronary atherectomy in heart transplant recipients. J Heart Lung Transplant (1993) 0.77
Coronary angioplasty in cardiac transplant patients. Results of a multicenter study. Circulation (1992) 0.77
Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med (2011) 0.77
The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant (1996) 0.77
Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant (1996) 0.77
Virus-specific MHC-restricted T lymphocytes may initiate allograft rejection. Immunol Today (1985) 0.77
Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation (1992) 0.77
OKT3-induced hypotension in heart allograft recipients treated for steroid-resistant rejection. J Heart Transplant (1989) 0.76
Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation (1990) 0.76
A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Transplantation (1989) 0.76
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation (1987) 0.76
Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. J Heart Lung Transplant (1997) 0.75
OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. J Heart Lung Transplant (1992) 0.75
Arteritis in cardiac rejection after transplantation. Am J Cardiol (1987) 0.75
Immunosuppression following cardiac transplantation. Cardiol Clin (1990) 0.75
Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial. J Heart Lung Transplant (1993) 0.75
Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma. J Heart Transplant (1985) 0.75
Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Circulation (1990) 0.75
Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression. J Heart Lung Transplant (1992) 0.75
Can we assess the changes of ventricular filling resulting from acute allograft rejection with Doppler echocardiography? J Heart Transplant (1989) 0.75
Reversal of recalcitrant cardiac allograft rejection with methotrexate. Circulation (1988) 0.75
The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc (1995) 0.75
Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection. J Heart Lung Transplant (1992) 0.75
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci (1991) 5.88
Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol (1988) 5.54
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med (1990) 3.88
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Inner-city residents, ethnic minorities and primary health care. Postgrad Med J (1983) 2.70
The development of smoking during adolescence--the MRC/Derbyshire Smoking Study. Int J Epidemiol (1983) 2.61
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav (1991) 2.57
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther (1993) 2.40
Improving classroom behavior in mentally retarded children through correspondence training. J Appl Behav Anal (1982) 2.39
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
Response deprivation and reinforcement in applied settings: A preliminary analysis. J Appl Behav Anal (1980) 1.83
Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv (2000) 1.78
Head-to-cervix force: an important physiological variable in labour. 2. Peak active force, peak active pressure and mode of delivery. Br J Obstet Gynaecol (1996) 1.75
Head-to-cervix force: an important physiological variable in labour. 1. The temporal relation between head-to-cervix force and intrauterine pressure during labour. Br J Obstet Gynaecol (1996) 1.67
Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation (2001) 1.62
ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J (2006) 1.59
Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther (1988) 1.58
Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens. J Heart Lung Transplant (1993) 1.52
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am J Trop Med Hyg (1998) 1.47
Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses. Catheter Cardiovasc Interv (1999) 1.46
The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci (1990) 1.42
Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther (1992) 1.41
Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression. J Heart Lung Transplant (1992) 1.41
Evidence of impaired microvascular function in pre-eclampsia: a non-invasive study. Clin Sci (Lond) (2003) 1.41
Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation. J Heart Lung Transplant (1998) 1.39
Birth weight: nature or nurture? Early Hum Dev (1995) 1.36
Visual estimates of percent diameter coronary stenosis: "a battered gold standard". J Am Coll Cardiol (1988) 1.36
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain (2001) 1.32
Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg (2001) 1.30
The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev Biol (1996) 1.29
Sensitivity and specificity of assessing coronary bypass graft patency with ultrafast computed tomography: results of a multicenter study. J Am Coll Cardiol (1988) 1.29
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem (1991) 1.23
Identification of a serine hydrolase as a key determinant in the microbial degradation of polychlorinated biphenyls. J Biol Chem (2000) 1.23
Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol (1988) 1.23
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet (2004) 1.23
Endometrial thickness: a predictor of implantation in ovum recipients? Hum Reprod (1994) 1.22
Tripartite sequences within and 3' to the sea urchin H2A histone gene display properties associated with a transcriptional termination process. Mol Cell Biol (1986) 1.22
Some factors associated with increased risk of smoking by children. J Child Psychol Psychiatry (1983) 1.18
Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS (1999) 1.18
A self-instructional package for increasing attending behavior in educable mentally retarded children. J Appl Behav Anal (1980) 1.18
The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil. Pharmacology (2000) 1.17
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin Cancer Res (2000) 1.14
The future direction of the adult heart allocation system in the United States. Am J Transplant (2015) 1.13
Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies. Am J Med Genet (1995) 1.13
Antenatal corticosteroid therapy and risk of osteoporosis. Br J Obstet Gynaecol (1998) 1.12
Serological survey for diseases in free-ranging coyotes (Canis latrans) in Yellowstone National Park, Wyoming. J Wildl Dis (1997) 1.12
The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase--GW311616A a development candidate. Bioorg Med Chem Lett (2001) 1.11
Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. J Biol Chem (1994) 1.09
The effect of coronary angioplasty on coronary flow reserve. Circulation (1988) 1.08
Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod (2004) 1.07
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol (1995) 1.06
The relationship between leptin concentration and bone metabolism in the human fetus. J Clin Endocrinol Metab (2000) 1.04
Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod (1993) 1.04
Teachers' smoking. J Epidemiol Community Health (1979) 1.03
Functional role of GTPase-activating protein in cell transformation by pp60v-src. Mol Cell Biol (1993) 1.01
Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety (1999) 0.98
Trends in children's smoking. Community Med (1980) 0.97
Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance. Clin Cancer Res (1999) 0.96
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety (2001) 0.96
Anharmonic motions of Kr in the clathrate hydrate. Nat Mater (2005) 0.96
Ethnic minorities and health. J R Coll Physicians Lond (1984) 0.96
Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant (1990) 0.96
Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant (1999) 0.96
Recall of lecture information: a question of what, when and where. Med Educ (1982) 0.95
The mitogen-activated protein kinase dependent expression of prostaglandin H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1{beta}. J Clin Endocrinol Metab (2005) 0.95
Medical teaching of the cultural aspects of ethnic minorities: does it exist? Med Educ (1986) 0.95
The effect of cholera toxin and heat labile and heat stable Escherichia coli enterotoxin on cyclic AMP concentrations in small intestinal mucosa of pig and rabbit. Can J Comp Med (1978) 0.94
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol Pharmacol (1994) 0.94
Oversizing of donor hearts: beneficial or detrimental? J Heart Lung Transplant (1992) 0.93
Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria. Mol Genet Metab (2010) 0.92
Further observations on cerebral or retinal ischemia in patients with right-left intracardiac shunts. Arch Neurol (1987) 0.91
Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol Pharmacol (1993) 0.91
Heart disease--why is maternal mortality increasing? BJOG (2009) 0.91
Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells. J Biol Chem (2000) 0.90
Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol (1996) 0.89
Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod (2000) 0.88
Successful treatment of heart transplant rejection with photopheresis. Transplantation (1992) 0.88
Nomenclature for human DPYD alleles. Pharmacogenetics (1998) 0.88
Cholera toxin effects on fluid secretion, adenylate cyclase, and cyclic AMP in porcine small intestine. Infect Immun (1978) 0.88
Myometrial prostaglandin E2 synthetic enzyme mRNA expression: spatial and temporal variations with pregnancy and labour. Mol Hum Reprod (2006) 0.87
Antenatal dexamethasone and the growth hormone-insulin-like growth factor axis. Hum Reprod (2000) 0.87
Serum concentrations of steroid hormones during reproduction in the Atlantic stingray, Dasyatis sabina. Gen Comp Endocrinol (1997) 0.87
Mechanical stretch of human uterine smooth muscle cells increases IL-8 mRNA expression and peptide synthesis. Mol Hum Reprod (2004) 0.87
In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol Endocrinol (1990) 0.87
Creation of a standardized geometry of the human nasal cavity. J Appl Physiol (1985) (2009) 0.87
Working in a developing country. Returned volunteers can advise. BMJ (1995) 0.86
Intermolecular interactions in solid benzene. J Chem Phys (2006) 0.86
Pulmonary hypertension and pregnancy--a review of 12 pregnancies in nine women. BJOG (2012) 0.86
Neurofibromatosis 1 and multiple sclerosis. J Neurol Neurosurg Psychiatry (1995) 0.86
Uterine stretch and progesterone action. J Clin Endocrinol Metab (2011) 0.85
Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry (1998) 0.84
A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod (2000) 0.84
Relationship between symptom over-reporting and pre- and post-combat trauma history in veterans evaluated for PTSD. Depress Anxiety (1999) 0.84
Echocardiographic evaluation of young adults with nonhemorrhagic cerebral infarction. Stroke (1986) 0.84
Prototype cannabinoid analgetics, prostaglandins and opiates--a search for points of mechanistic interaction. Life Sci (1983) 0.83
Serologic survey for infectious pathogens in free-ranging American bison. J Wildl Dis (1997) 0.83
Heart transplantation in the United States, 1998-2007. Am J Transplant (2009) 0.83